Lin Y, Qin S, Yang H, Shi F, et al. Multicenter randomized double-blind phase III trial of donafenib in progressive radioactive iodine-refractory differentiated thyroid cancer. Clin Cancer Res 2023 May 15:CCR-22-3613. doi: 10.1158/1078-0432.CCR-22-3613.
PMID: 37184934